Early cognitive function tests predict early progression in glioblastoma-Reference-Cited by-同舟云学术

Early cognitive function tests predict early progression in glioblastoma

Published:2015-05-12 Issue:3 Volume:2 Page:137-143
ISSN:2054-2577
Container-title:Neuro-Oncology Practice
language:en
Short-container-title:Neuro Oncol Pract

Author:

Lee Soon-Tae,Park Chul-Kee,Kim Jin Wook,Park Min-Jung,Lee Hyon,Lim Jung-Ah,Choi Seung Hong,Kim Tae Min,Lee Se-Hoon,Park Sung-Hye,Kim Il Han,Lee Kyoung-Min

Publisher

Oxford University Press (OUP)

Subject

Medicine (miscellaneous)

Link

http://academic.oup.com/nop/article-pdf/2/3/137/6300152/npv007.pdf

Reference32 articles.

1. Cognitive Deficits before Treatment among Patients with Brain Tumors

2. Klein M Taphoorn MJ Heimans JJ Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patients. J Clin Oncol. 2001;19 (20):4037–4047.

3. Detrimental Effects of Tumor Progression on Cognitive Function of Patients With High-Grade Glioma

4. Taylor BV Buckner JC Cascino TL Effects of radiation and chemotherapy on cognitive function in patients with high-grade glioma. J Clin Oncol. 1998;16 (6):2195–2201.

5. Cognitive deficits in adult patients with brain tumours

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cognitive functioning is prognostic in patients with IDH1-wild type and MGMT-unmethylated high-grade gliomas;Croatian Medical Journal;2023-12

2. The influence of glioblastoma on patients' cognitive and demographic characteristics and psychological well‐being of patients and caregivers: a single‐centre retrospective study;Psychogeriatrics;2023-09-26

3. Baseline neurocognitive dysfunction is ubiquitous in intrinsic brain tumors– results from a large Indian cohort of patients and analysis of factors associated with domain-specific dysfunction;World Neurosurgery: X;2023-07

4. Cognitive functioning in a cohort of high-grade glioma patients;Radiology and Oncology;2023-06-01

5. Preoperative neurocognitive function as an independent survival prognostic marker in primary glioblastoma;Neuro-Oncology Practice;2023-05-11